Jonathan P. Ling

3.4k total citations · 2 hit papers
26 papers, 1.4k citations indexed

About

Jonathan P. Ling is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Jonathan P. Ling has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Neurology and 9 papers in Genetics. Recurrent topics in Jonathan P. Ling's work include Amyotrophic Lateral Sclerosis Research (14 papers), RNA Research and Splicing (10 papers) and Neurogenetic and Muscular Disorders Research (9 papers). Jonathan P. Ling is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (14 papers), RNA Research and Splicing (10 papers) and Neurogenetic and Muscular Disorders Research (9 papers). Jonathan P. Ling collaborates with scholars based in United States, United Kingdom and Germany. Jonathan P. Ling's co-authors include Philip C. Wong, Juan C. Troncoso, Olga Pletniková, Yun Ha Jeong, Po‐Min Chiang, Donald L. Price, Susan Aja, Kerstin E. Braunstein, Aneesh Donde and Katherine D. LaClair and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Jonathan P. Ling

23 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD

2015 387 citations Jonathan P. Ling, Olga Pletniková et al. Science profile →
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD

2024 52 citations Katherine E. Irwin, Kerstin E. Braunstein et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan P. Ling United States	17	836	820	556	169	144	26	1.4k
Basar Cenik United States	10	930 1.1×	733 0.9×	440 0.8×	274 1.6×	115 0.8×	13	1.4k
Yohei Iguchi Japan	20	951 1.1×	983 1.2×	595 1.1×	227 1.3×	179 1.2×	45	1.7k
Nicole Hersmus Belgium	14	644 0.8×	610 0.7×	446 0.8×	122 0.7×	240 1.7×	19	1.2k
Max Koppers Netherlands	15	921 1.1×	1.0k 1.3×	612 1.1×	234 1.4×	332 2.3×	23	1.8k
Nicholas J. Kramer United States	11	688 0.8×	715 0.9×	307 0.6×	158 0.9×	264 1.8×	13	1.2k
Anna M. Blokhuis Netherlands	7	655 0.8×	451 0.6×	412 0.7×	152 0.9×	151 1.0×	7	929
Elisa Onesto Italy	17	715 0.9×	819 1.0×	411 0.7×	161 1.0×	337 2.3×	18	1.3k
Peggy Allred United States	12	663 0.8×	694 0.8×	566 1.0×	150 0.9×	267 1.9×	18	1.4k
Claudia Fallini United States	19	781 0.9×	1.4k 1.7×	879 1.6×	112 0.7×	212 1.5×	24	1.8k
Iga Wegorzewska United States	11	750 0.9×	889 1.1×	383 0.7×	222 1.3×	371 2.6×	12	1.5k

Countries citing papers authored by Jonathan P. Ling

Since Specialization

Citations

This map shows the geographic impact of Jonathan P. Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan P. Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan P. Ling more than expected).

Fields of papers citing papers by Jonathan P. Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan P. Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan P. Ling. The network helps show where Jonathan P. Ling may publish in the future.

Co-authorship network of co-authors of Jonathan P. Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan P. Ling. A scholar is included among the top collaborators of Jonathan P. Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan P. Ling. Jonathan P. Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sinha, Irika R., Katherine E. Irwin, Anna Lourdes Cruz, et al.. (2025). Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons. Nature Communications. 16(1). 6878–6878. 1 indexed citations

Ikenaga, Chiseko, Katherine E. Irwin, Irika R. Sinha, et al.. (2025). Loss of TDP‐43 Splicing Repression Occurs in Myonuclei of Inclusion Body Myositis Patients. Annals of Neurology. 97(4). 629–641. 1 indexed citations

Haruhara, Kotaro, David J. Nikolic‐Paterson, Peter G. Kerr, et al.. (2024). Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis. Frontiers in Medicine. 11. 1343161–1343161.

Irwin, Katherine E., Irika R. Sinha, Rachael E. Wilson, et al.. (2024). Novel fluid biomarker detects TDP‐43 loss of function in individuals at elevated risk of Alzheimer’s disease. Alzheimer s & Dementia. 20(S8).

Irwin, Katherine E., Kerstin E. Braunstein, Irika R. Sinha, et al.. (2024). A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD. Nature Medicine. 30(2). 382–393. 52 indexed citations breakdown →

Zhang, Xi, et al.. (2024). Multivalent GU-rich oligonucleotides sequester TDP-43 in the nucleus by inducing high molecular weight RNP complexes. iScience. 27(6). 110109–110109. 3 indexed citations

Tsao, William, Irika R. Sinha, Koping Chang, et al.. (2024). Elevated nuclear TDP-43 induces constitutive exon skipping. Molecular Neurodegeneration. 19(1). 45–45. 10 indexed citations

Chang, Koping, Jonathan P. Ling, Javier Redding‐Ochoa, et al.. (2023). Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline. Acta Neuropathologica. 147(1). 4–4. 16 indexed citations

Britson, Kyla A., Jonathan P. Ling, Kerstin E. Braunstein, et al.. (2022). Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Science Translational Medicine. 14(628). eabi9196–eabi9196. 34 indexed citations

10.

Kim, Dong Won, Anabel Gonzalez-Gil, Kerstin E. Braunstein, et al.. (2022). Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes. Molecular Neurodegeneration. 17(1). 83–83. 41 indexed citations

11.

Ling, Jonathan P., Abraham J. Langseth, Ari Waisman, et al.. (2022). Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43. eLife. 11. 23 indexed citations

12.

Wilks, Christopher, Shijie Zheng, Brad Solomon, et al.. (2021). recount3: summaries and queries for large-scale RNA-seq expression and splicing. Genome biology. 22(1). 323–323. 114 indexed citations

13.

Ling, Jonathan P., Christopher Wilks, Patrick J. Leavey, et al.. (2020). ASCOT identifies key regulators of neuronal subtype-specific splicing. Nature Communications. 11(1). 137–137. 45 indexed citations

14.

Donde, Aneesh, Mingkuan Sun, Yun Ha Jeong, et al.. (2019). Upregulation of ATG7 attenuates motor neuron dysfunction associated with depletion of TARDBP/TDP-43. Autophagy. 16(4). 672–682. 31 indexed citations

15.

Donde, Aneesh, Mingkuan Sun, Jonathan P. Ling, et al.. (2019). Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathologica. 138(5). 813–826. 60 indexed citations

16.

Lynch, Kristen W., et al.. (2018). HnRNP L represses cryptic exons. RNA. 24(6). 761–768. 29 indexed citations

17.

Jeong, Yun Ha, Jonathan P. Ling, Aneesh Donde, et al.. (2017). Tdp-43 cryptic exons are highly variable between cell types. Molecular Neurodegeneration. 12(1). 13–13. 57 indexed citations

18.

Ling, Jonathan P., Resham Chhabra, Paul Schaughency, et al.. (2016). PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons. Cell Reports. 17(1). 104–113. 50 indexed citations

19.

Ling, Jonathan P., Olga Pletniková, Juan C. Troncoso, & Philip C. Wong. (2015). TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 349(6248). 650–655. 387 indexed citations breakdown →

20.

Nakabayashi, Mari, Jonathan P. Ling, Wanling Xie, Meredith M. Regan, & William Oh. (2007). Response to Vinorelbine With or Without Estramustine as Second-Line Chemotherapy in Patients with Hormone-Refractory Prostate Cancer. The Cancer Journal. 13(2). 125–129. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact